{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:33:30Z","timestamp":1792802010146,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sponsored by Science Foundation of AMHT","award":["2023YK06"],"award-info":[{"award-number":["2023YK06"]}]},{"name":"Beijing Gold-Bridge Project","award":["ZZ21043"],"award-info":[{"award-number":["ZZ21043"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05730-6","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:54:02Z","timestamp":1731588842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of functional characterization of cancer stem cells in different tumor tissues of pseudomyxoma peritonei"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2240-5362","authenticated-orcid":false,"given":"Haipeng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubiao","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanjun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"5730_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4613-1245-1_10","volume":"81","author":"PH Sugarbaker","year":"1996","unstructured":"Sugarbaker PH. Pseudomyxoma Peritonei. Cancer Treat Res. 1996;81:105\u201319.","journal-title":"Cancer Treat Res"},{"key":"5730_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.12659\/AJCR.890837","volume":"15","author":"C Spyropoulos","year":"2014","unstructured":"Spyropoulos C, Rentis A, Alexaki E, Triantafillidis JK, Vagianos C. Appendiceal mucocele and pseudomyxoma peritonei; the clinical boundaries of a subtle disease. Am J Case Rep. 2014;15:355\u201360.","journal-title":"Am J Case Rep"},{"issue":"8","key":"5730_CR3","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1002\/ijc.33460","volume":"148","author":"B Wang","year":"2021","unstructured":"Wang B, Yao J, Ma R, Liu D, Lu Y, Shi G, An L, Xia A, Chen F, Pang S, Zhai X, Liu G, Chen S, Xu M, Song L, Xu H. The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovary. Int J Cancer. 2021;148(8):2036\u201347.","journal-title":"Int J Cancer"},{"issue":"1","key":"5730_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejso.2020.02.012","volume":"47","author":"K Govaerts","year":"2021","unstructured":"Govaerts K, Lurvink RJ, De Hingh IHJT, Van der Speeten K, Villeneuve L, Kusamura S, Kepenekian V, Deraco M, Glehen O, Moran BJ, PSOGI. Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol. 2021;47(1):11\u201335.","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"5730_CR5","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1046\/j.1365-2168.1998.00882.x","volume":"85","author":"FL Hinson","year":"1998","unstructured":"Hinson FL, Ambrose NS. Pseudomyxoma Peritonei. Br J Surg. 1998;85(10):1332\u20139.","journal-title":"Br J Surg"},{"issue":"8","key":"5730_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1067\/j.cpsurg.2008.04.003","volume":"45","author":"RM Smeenk","year":"2008","unstructured":"Smeenk RM, Bruin SC, van Velthuysen ML, Verwaal VJ. Pseudomyxoma Peritonei. Curr Probl Surg. 2008;45(8):527\u201375.","journal-title":"Curr Probl Surg"},{"issue":"5","key":"5730_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/02656736.2017.1310938","volume":"33","author":"R Mittal","year":"2017","unstructured":"Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperth. 2017;33(5):511\u20139.","journal-title":"Int J Hyperth"},{"issue":"4","key":"5730_CR8","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s11605-019-04239-4","volume":"24","author":"V Narasimhan","year":"2020","unstructured":"Narasimhan V, Wilson K, Britto M, Warrier S, Lynch AC, Michael M, Tie J, Akhurst T, Mitchell C, Ramsay R, Heriot A. Outcomes following cytoreduction and HIPEC for Pseudomyxoma Peritonei: 10-Year experience. J Gastrointest Surg. 2020;24(4):899\u2013906.","journal-title":"J Gastrointest Surg"},{"issue":"1\u20132","key":"5730_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/ans.18041","volume":"93","author":"R Ma","year":"2023","unstructured":"Ma R, Lu D, Xue S, Fan X, Zhai X, Wang C, Xu H, Pang S. Preoperative systemic chemotherapy does not benefit for appendiceal pseudomyxoma peritonei. ANZ J Surg. 2023;93(1\u20132):219\u201326.","journal-title":"ANZ J Surg"},{"key":"5730_CR10","doi-asserted-by":"publisher","first-page":"155227","DOI":"10.1016\/j.prp.2024.155227","volume":"256","author":"A Gholamzad","year":"2024","unstructured":"Gholamzad A, Khakpour N, Khosroshahi EM, Asadi S, Koohpar ZK, Matinahmadi A, Jebali A, Rashidi M, Hashemi M, Sadi FH, Gholamzad M. Cancer stem cells: the important role of CD markers, signaling pathways, and MicroRNAs. Pathol Res Pract. 2024;256:155227.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"5730_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1073\/pnas.0610117104","volume":"104","author":"ME Prince","year":"2007","unstructured":"Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007;104(3):973\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"43","key":"5730_CR12","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1038\/sj.onc.1207946","volume":"23","author":"SK Singh","year":"2004","unstructured":"Singh SK, Clarke ID, Hide T, Dirks PB. Cancer stem cells in nervous system tumors. Oncogene. 2004;23(43):7267\u201373.","journal-title":"Oncogene"},{"issue":"7","key":"5730_CR13","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3983\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5730_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-59745-280-9_10","volume":"568","author":"C Li","year":"2009","unstructured":"Li C, Lee CJ, Simeone DM. Identification of human pancreatic cancer stem cells. Methods Mol Biol. 2009;568:161\u201373.","journal-title":"Methods Mol Biol"},{"issue":"4","key":"5730_CR15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ccr.2013.03.023","volume":"23","author":"B Sainz Jr","year":"2013","unstructured":"Sainz B Jr, Heeschen C. Standing out from the crowd: cancer stem cells in hepatocellular carcinoma. Cancer Cell. 2013;23(4):431\u20133.","journal-title":"Cancer Cell"},{"issue":"3","key":"5730_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/1061186X.2018.1479756","volume":"27","author":"A Barzegar Behrooz","year":"2019","unstructured":"Barzegar Behrooz A, Syahir A, Ahmad S. CD133: beyond a cancer stem cell biomarker. J Drug Target. 2019;27(3):257\u201369.","journal-title":"J Drug Target"},{"key":"5730_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cytogfr.2021.07.001","volume":"61","author":"F Ferragut","year":"2021","unstructured":"Ferragut F, Vachetta VS, Troncoso MF, Rabinovich GA, Elola MT. ALCAM\/CD166: a pleiotropic mediator of cell adhesion, stemness and cancer progression. Cytokine Growth Factor Rev. 2021;61:27\u201337.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"5730_CR18","doi-asserted-by":"publisher","first-page":"e66371","DOI":"10.1371\/journal.pone.0066371","volume":"8","author":"PC Hermann","year":"2013","unstructured":"Hermann PC, Trabulo SM, Sainz B Jr, Balic A, Garcia E, Hahn SA, Vandana M, Sahoo SK, Tunici P, Bakker A, Hidalgo M, Heeschen C. Multimodal Treatment eliminates Cancer Stem cells and leads to long-term survival in primary human pancreatic Cancer tissue xenografts. PLoS ONE. 2013;8(6):e66371.","journal-title":"PLoS ONE"},{"issue":"1","key":"5730_CR19","doi-asserted-by":"publisher","first-page":"113904","DOI":"10.1016\/j.yexcr.2023.113904","volume":"435","author":"G Abbas","year":"2024","unstructured":"Abbas G, Saluja TS, Kumar D, Agrawal H, Gupta A, Panday G, Singh SK. Antitumor efficacy of synthesized Ag-Au nanocomposite loaded with PEG and ascorbic acid in human lung cancer stem cells. Exp Cell Res. 2024;435(1):113904.","journal-title":"Exp Cell Res"},{"issue":"1","key":"5730_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/j.gastro.2023.09.040","volume":"166","author":"H Kim","year":"2024","unstructured":"Kim H, Jang B, Zhang C, Caldwell B, Park DJ, Kong SH, Lee HJ, Yang HK, Goldenring JR, Choi E. Targeting stem cells and dysplastic features with Dual MEK\/ERK and STAT3 suppression in gastric carcinogenesis. Gastroenterology. 2024;166(1):117\u201331.","journal-title":"Gastroenterology"},{"issue":"3","key":"5730_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s12094-023-03297-0","volume":"26","author":"L Moradi","year":"2024","unstructured":"Moradi L, Tajik F, Saeednejad Zanjani L, Panahi M, Gheytanchi E, Biabanaki ZS, Kazemi-Sefat GE, Hashemi F, Dehghan Manshadi M, Madjd Z. Clinical significance of CD166 and HER-2 in different types of gastric cancer. Clin Transl Oncol. 2024;26(3):664\u201381.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"5730_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","volume":"7","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7(1):69\u201376.","journal-title":"Lancet Oncol"},{"issue":"4","key":"5730_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/mutage\/gey021","volume":"33","author":"JR Verma","year":"2018","unstructured":"Verma JR, Harte DSG, Shah UK, Summers H, Thornton CA, Doak SH, Jenkins GJS, Rees P, Wills JW, Johnson GE. Investigating FlowSight\u00ae imaging flow cytometry as a platform to assess chemically induced micronuclei using human lymphoblastoid cells in vitro. Mutagenesis. 2018;33(4):283\u20139.","journal-title":"Mutagenesis"},{"issue":"1","key":"5730_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12967-021-02857-8","volume":"19","author":"H Zhou","year":"2021","unstructured":"Zhou H, He Y, Wang Z, Wang Q, Hu C, Wang X, Lu S, Li K, Yang Y, Luan Z. Identifying the functions of two biomarkers in human oligodendrocyte progenitor cell development. J Transl Med. 2021;19(1):188.","journal-title":"J Transl Med"},{"issue":"8","key":"5730_CR25","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.it.2023.05.007","volume":"44","author":"J Huyghe","year":"2023","unstructured":"Huyghe J, Priem D, Bertrand MJM. Cell death checkpoints in the TNF pathway. Trends Immunol. 2023;44(8):628\u201343.","journal-title":"Trends Immunol"},{"issue":"3","key":"5730_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.soc.2018.02.001","volume":"27","author":"PH Sugarbaker","year":"2018","unstructured":"Sugarbaker PH. Peritoneal metastases, a Frontier for Progress. Surg Oncol Clin N Am. 2018;27(3):413\u201324.","journal-title":"Surg Oncol Clin N Am"},{"issue":"1","key":"5730_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","volume":"40","author":"NJ Carr","year":"2016","unstructured":"Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, Gonz\u00e1lez-Moreno S, Taflampas P, Chapman S, Moran BJ, Peritoneal Surface Oncology Group International. A Consensus for classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am J Surg Pathol. 2016;40(1):14\u201326.","journal-title":"Am J Surg Pathol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05730-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05730-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05730-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T13:04:14Z","timestamp":1731589454000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05730-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5730"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05730-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"17 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human tissues were handled in accordance with protocols approved by the hospital\u2019s Ethics Committee (Application No. 2024-024). The patients or their guardians\/legally authorized representatives\/next of kin provided written informed consent for the use of samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1022"}}